Effect of steroid hormones and retinoids on the formation of capillary- like tubular structures of human microvascular endothelial cells in fibrin matrices is related to urokinase expression

Blood

Volumn 92, Issue 3, 1998, Pages 927-938

  Lansink, Mirian ^a   Koolwijk, Pieter ^a   Van Hinsbergh, Victor ^a   Kooistra, Teake ^a  

^a TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; APROTININ; CALCITRIOL; DEXAMETHASONE; ESTRADIOL; FIBRIN; HORMONE RECEPTOR; PLASMIN; PLASMINOGEN ACTIVATOR; PROGESTERONE; RETINOIC ACID; RETINOID; STEROID HORMONE; TESTOSTERONE; THYROID HORMONE; THYROID HORMONE RECEPTOR; UROKINASE;

ANGIOGENESIS; ARTICLE; CAPILLARY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; INFLAMMATION; NORTHERN BLOTTING; PREPUCE; PRIORITY JOURNAL; TRANSCRIPTION INITIATION;

EID: 0032147231     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.3.927.415k15_927_938     Document Type: Article

References (66)

1. Liotta LA, Steeg PS, Stetler-Stevenson WG: Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 64:327, 1991
2. Folkman J, Shing Y: Angiogenesis. J Biol Chem 267:10931, 1992
3. Montesano R: Regulation of angiogenesis in vitro. Eur J Clin Invest 22:504, 1992
4. Colville-Nash PR, Scott DL: Angiogenesis and rheumatoid arthritis-pathogenic and therapeutic implications. Ann Rheum Dis 51:919, 1992
5. Risau W: Mechanisms of angiogenesis. Nature 386:671, 1997
6. Folkman J: How is blood vessel growth regulated in normal tissue and neoplastic tissue? G.H.A. Clowes Memorial Award Lecture. Cancer Res 46:467, 1986
7. Pepper M: Manipulating angiogenesis: From basic science to bedside. Arterioscl Thromb Vase Biol 17:605, 1997
8. Gross J, Azizkhan RG, Biswas C, Bruns RR, Hsieh DST, Folkman J: Inhibition of tumor growth, vascularisation and collagenolysis in the rabbit cornea by medroxyprogesterone. Proc Natl Acad Sci USA 78:1176, 1981
9. Oikawa T, Hirotani K, Nakamura O, Shudo K, Hiragun A, Iwaguchi T: A highly potent antiangiogenic activity of retinoids. Cancer Lett 48:157, 1989
10. Oikawa T, Okayasu I, Ashino H, Morita I, Murota S, Shudo K: Three novel synthetic retinoids, Re 80, Am 580 and Am 80, all exhibit anti-angiogenic activity in vivo. Eur J Pharmacol 249:113, 1993
11. Brown RA, Rees JA, McFarland CD, Lewinson D, Ali SY: Microvascular invasion of rabbit growth plate cartilage and the influence of dexamethasone. Bone Miner 9:35, 1990
12. Gagliardi A, Collins DC: Inhibition of angiogenesis by antiestrogens. Cancer Res 53:533, 1993
13. Brandi ML, Crescioli C, Tanini A, Frediani U, Agnusdei D, Gennari C: Bone endothelial cells as estrogen targets. Calcif Tissue Int 53:312, 1993
14. Yamamoto T, Terada N, Nishizawa Y, Petrow V: Angiostatic activities of medroxyprogesterone acetate and its analogues. Int J Cancer 56:393, 1994
15. Fotsis T, Zhang YM, Pepper MS, Adlercreutz H, Montesano R, Nawroth PP, Schweigerer L: The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature 368:237, 1994
16. Hu DE, Hori Y, Presta M, Gresham GA, Fan TP: Inhibition of angiogenesis in rats by IL-1 receptor antagonist and selected cytokine antibodies. Inflammation 18:45, 1994
17. Morales DE, McGowan KA, Grant DS, Maheshwari S, Bhartiya D, Cid MC, Kleinman HK, Schnaper W: Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and a murine model. Circulation 91:755, 1995
18. Koolwijk P, Van Erck MGM, De Vree WJA, Vermeer MA, Weich HA, Hanemaaijer R, Van Hinsbergh VWM: Cooperative effect of TNFα, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity. J Cell Biol 132:1177, 1996
19. Dvorak HF, Nagy JA, Berse B, Brown LF, Yeo KT, Yeo TK, Dvorak AM, Vandewater L, Sioussat TM, Senger DR: Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation. Ann NY Acad Sci 667:101, 1992
20. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM: The nuclear receptor superfamily: The second decade. Cell 83:835, 1995
21. Van Hinsbergh VWM, Sprengers ED, Kooistra T: Effect of thrombin on the production of plasminogen activators and PA inhibitor-1 by human foreskin microvascular endothelial cells. Thromb Haemost 57:148, 1987
22. Maciag T, Cerundolo J, Ilsley S, Kelley PR, Forand R: An endothelial cell growth factor from bovine hypothalamus: Identification and partial characterization. Proc Natl Acad Sci USA 76:5674, 1979
23. Chomczynski P, Sacchi N: Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
24. Medcalf RL, Van den Berg E, Schleuning W-D: Glucocorticoid-modulated gene expression of tissue-and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2. J Cell Biol 106:971, 1988
25. Roldan AL, Cubellis MV, Masucci MT, Behrendt N, Lund LR, Danø K, Appella E, Blasi F: Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin-dependent proteolysis. EMBO J 9:467, 1990
26. Faber PW, Van Rooij HC, Van der Korput HA, Baarends WM, Brinkmann AO, Grootegoed JA, Trapman J: Characterization of the human androgen receptor transcription unit. J Biol Chem 266:10743, 1991
27. Caldenhoven E, Liden J, Wissink S, Van de Stolpe A, Raaijmakers J, Koenderman L, Okret S, Gustafsson JA, Van der Saag, PT: Negative cross-talk between RelA and the glucocorticoid receptor: A possible mechanism for the antiinflammatory action of glucocorticoids. Mol Endocrinol 9:401, 1995
28. Dodemont HJ, Soriano P, Quax WJ, Ramaekers F, Lenstra JA, Groenen MAM, Bernardi G, Bloemendal H: The genes coding for the cytoskeletal protein actin and vimentin in warm blooded vertebrates. EMBO J 1:167, 1982
29. Perrot-Applanat M, Cohen-Solal K, Milgrom E, Finet M: Progesterone receptor expression in human saphenous veins. Circulation 92:2975, 1995
30. Mosselman S, Polman J, Dijkema R: ERβ: Identification and characterization of a novel human estrogen receptor. FEBS Lett 392:49, 1996
31. Nakai A, Seino S, Sakurai A, Szilak I, Bell GI, DeGroot LJ: Characterization of a thyroid hormone receptor expressed in human kidney and other tissues. Proc Natl Acad Sci USA 85:2781, 1988
32. Weinburger C, Thompson CC, Ong ES, Lebo R, Gruol DJ, Evans RM: The c-erb-A gene encodes a thyroid hormone receptor. Nature 324:641, 1986
33. Baker AR, McDonnell DP, Hughes M, Crisp TM, Mangelsdorf DJ, Haussler MR, Pike JW, Shine J, O'Malley BW: Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci USA 85:3294, 1988
34. Kemppainen JA, Lane MV, Sar M, Wilson EM: Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. Specificity for steroids and antihormones. J Biol Chem 267:968, 1992
35. Wong C, Kelce WR, Sar M, Wilson EM: Androgen receptor antagonist versus agonist activities of the fungicide vinclozolin relative to hydroxyflutamide. J Biol Chem 270:19998, 1995
36. Cadepond F, Ulmann A, Baulieu EE: RU486 (mifepristone): Mechanisms of action and clinical uses. Annu Rev Med 48:129, 1997
37. Apfel C, Bauer F, Crettaz M, Forni L, Kamber M, Kaufmann F, LeMotte P, Pirson W, Klaus M: A retinoic acid receptor a antagonist selectively counteracts acid effects. Proc Natl Acad Sci USA 89:7129, 1992
38. Keidel S, LeMotte P, Apfel C: Different agonist- and antagonist-induced conformational changes in retinoic acid receptors analyzed by protease mapping. Mol Cell Biol 14:287, 1994
39. Yebra M, Parry GCN, Strömblad S, Mackman N, Rosenberg S, Mueller BM, Cheresh DA: Requirement of receptor-bound urokinase-type plasminogen activator for integrin αvβ5-directed cell migration. J Biol Chem 271:29393, 1996
40. Koshelnick Y, Ehart M, Hufnagl P, Heinrich PC, Binder BR: Urokinase receptor is associated with the components of the JAK1/ STAT1 signaling pathway and leads to activation of this pathway upon receptor clustering in the human kidney epithelial tumor cell line TCL-598. J Biol Chem 272:28563, 1997
41. Rabbani SA, Gladu J, Mazar AP, Henkin J, Goltzman D: Induction in human osteoblastic cells (SaOS(2)) of the early response genes fos, jun, and myc by the amino terminal fragment (ATF) of urokinase. J Cell Physiol 172:137, 1997
42. D'Amato RJ, Lin CM, Flynn E, Folkman J, Hamel E: 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site. Proc Natl Acad Sci USA 91:3964, 1994
43. κB and IκBα: An inducible regulatory system in endothelial activation. J Exp Med 179:503, 1994
44. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T: Transcriptional regulation of endothelial adhesion molecules: NFκB and cytokine-inducible enhancers. FASEB J 9:899, 1995
45. Besser D, Verde P, Nagamine Y, Blasi F: Signal transduction and the u-PA/u-PAR system. Fibrinolysis 4:215, 1996
46. König H, Ponta H, Rahmsdorf HJ, Herrlich P: Interference between pathway-specific transcription factors: Glucocorticoids antagonize phorbol ester-induced AP-1 activity without altering AP-1 site occupation in vivo. EMBO J 11:2241, 1992
47. Ray A, Prefontaine KE: Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc Natl Acad Sci USA 91:752, 1994
48. Scheinmann RI, Cogswell PC, Lofquist AK, Baldwin AS: Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science 270:283, 1995
49. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M: Immunosuppression by glucocorticoids: Inhibition of NFκB activity through induction of IκB synthesis. Science 270:286, 1995
50. Keller ET, Chang CS, Ershler WB: Inhibition of NFκB activity through maintenance of IκBα levels contributes to dihydrotestosterone-mediated repression of the interleukin-6 promoter. J Biol Chem 271:26267, 1996
51. Harant H, De Martin R, Andrew PJ, Foglar E, Dittrich C, Lindley IJD: Synergistic activation of interleukin-8 gene transcription by all-trans-retinoic acid and tumor necrosis factor α involves the transcription factor NF-κB. J Biol Chem 271:26954, 1996
52. Ellis V, Scully MF, Kakkar VV: Plasminogen activation initiated by single-chain urokinase plasminogen activator: Potentiation by U937 cells. J Biol Chem 264:2185, 1989
53. Stephens RW, Pöllänen J, Tapiovaara H, Leung K-C, Sim P-S, Salonen E-M, Rønne E, Behrendt N, Danø K, Vaheri A: Activation of pro-urokinase and plasminogen on human sarcoma cells: A proteolytic system with surface-bound reactants. J Cell Biol 108:1987, 1989
54. Wei Y, Waltz DA, Rao N, Drummond RJ, Rosenberg S, Chapman HA: Identification of the urokinase receptor as an adhesion receptor for vitronectin. J Biol Chem 269:32380, 1994
55. Rastinejad F, Polverini PJ, Bouck NP: Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 56:345, 1989
56. Iruela-Arispe ML, Bornstein P, Sage H: Thrombospondin exerts an antiangiogenic effect on tube formation by endothelial cells in vitro. Proc Natl Acad Sci USA 88:5026, 1991
57. Iruela-Arispe ML, Porter P, Bornstein P, Sage EH: Thrombospondin-1, an inhibitor of angiogenesis, is regulated by progesterone in the human endometrium. J Clin Invest 97:403, 1996
58. Dedhar S, Robertson K, Gray V: Induction of expression of the αvβ1 and αvβ3 integrin heterodimers during retinoic acid-induced neuronal differentiation of murine embryonal carcinoma cells. J Biol Chem 266:21846, 1991
59. Laurikainen L, Carey T, Peltonen J: The expression of α6 and β4 integrin genes are differentially regulated by all-trans-retinoic acid (RA) in cultured human keratinocytes. Arch Dermatol Res 288:270, 1996
60. Varner JA, Cheresh DA: Integrins and cancer. Curr Opin Cell Biol 8:724, 1996
61. Lafyatis R, Kim SJ, Angel P, Roberts AB, Sporn MB, Karin M, Wilder RL: Interleukin-1 stimulates and all-trans retinoic acid inhibits Collagenase gene expression through its 5′ activator protein-1 binding site. Mol Endocrinol 4:973, 1990
62. Frisch SM, Ruley HE: Transcription from the stromelysin promoter is induced by interleukin 1 and repressed by dexamethasone. J Biol Chem 262:3535, 1987
63. Offringa R, Smis AM, Houweling A, Bos JL, van der Eb AJ: Similar effects of adenovirus E1 A and glucocorticoid hormones on the expression of the metalloprotease stromelysin. Nucleic Acids Res 16:10974, 1988
64. Jonat G, Rahmsdorf HJ, Park KK, Cato ACB, Gebel S, Ponta H, Herrlich P: Antitumor promotion and inflammation: Down-regulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62:1189, 1990
65. Yang-Yen HF, Chambard JC, Sun YL, Smeal T, Schmidt TJ, Drouin J, Karin M: Transcriptional interference between c-Jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62:1205, 1990
66. Pepper MS, Vassalli J-D, Wilks JW, Schweigerer L, Orci L, Montesano R: Modulation of bovine microvascular endothelial cell proteolytic properties by inhibitors of angiogenesis. J Cell Biochem 55:419, 1994